These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 9758306)
1. Levofloxacin, a second-generation fluoroquinolone. North DS; Fish DN; Redington JJ Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306 [TBL] [Abstract][Full Text] [Related]
2. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Croom KF; Goa KL Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657 [TBL] [Abstract][Full Text] [Related]
3. The clinical pharmacokinetics of levofloxacin. Fish DN; Chow AT Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926 [TBL] [Abstract][Full Text] [Related]
5. Levofloxacin and sparfloxacin: new quinolone antibiotics. Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064 [TBL] [Abstract][Full Text] [Related]
6. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Davis R; Bryson HM Drugs; 1994 Apr; 47(4):677-700. PubMed ID: 7516863 [TBL] [Abstract][Full Text] [Related]
7. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)]. Scheen AJ Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704 [TBL] [Abstract][Full Text] [Related]
8. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones? Ernst ME; Ernst EJ; Klepser ME Am J Health Syst Pharm; 1997 Nov; 54(22):2569-84. PubMed ID: 9397218 [TBL] [Abstract][Full Text] [Related]
9. Gatifloxacin, an advanced 8-methoxy fluoroquinolone. Fish DN; North DS Pharmacotherapy; 2001 Jan; 21(1):35-59. PubMed ID: 11191737 [TBL] [Abstract][Full Text] [Related]
10. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials. Symonds WT; Nix DE Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892 [TBL] [Abstract][Full Text] [Related]
13. Levofloxacin for the treatment of community-acquired pneumonia. Lynch JP; File TM; Zhanel GG Expert Rev Anti Infect Ther; 2006 Oct; 4(5):725-42. PubMed ID: 17140350 [TBL] [Abstract][Full Text] [Related]
14. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections. Martin SJ; Jung R; Garvin CG Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723 [TBL] [Abstract][Full Text] [Related]
15. Levofloxacin: an updated review of its use in the treatment of bacterial infections. Hurst M; Lamb HM; Scott LJ; Figgitt DP Drugs; 2002; 62(14):2127-67. PubMed ID: 12269858 [TBL] [Abstract][Full Text] [Related]
16. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Langtry HD; Lamb HM Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318 [TBL] [Abstract][Full Text] [Related]